These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 34237332)

  • 1. Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFAS) and child executive function and behavioral problems.
    Harris MH; Oken E; Rifas-Shiman SL; Calafat AM; Bellinger DC; Webster TF; White RF; Sagiv SK
    Environ Res; 2021 Nov; 202():111621. PubMed ID: 34237332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFASs) and child cognition.
    Harris MH; Oken E; Rifas-Shiman SL; Calafat AM; Ye X; Bellinger DC; Webster TF; White RF; Sagiv SK
    Environ Int; 2018 Jun; 115():358-369. PubMed ID: 29705692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral difficulties in 7-year old children in relation to developmental exposure to perfluorinated alkyl substances.
    Oulhote Y; Steuerwald U; Debes F; Weihe P; Grandjean P
    Environ Int; 2016 Dec; 97():237-245. PubMed ID: 27692925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and neurobehavior in US children through 8 years of age: The HOME study.
    Vuong AM; Webster GM; Yolton K; Calafat AM; Muckle G; Lanphear BP; Chen A
    Environ Res; 2021 Apr; 195():110825. PubMed ID: 33545124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral outcomes and exposure to perfluoroalkyl substances among children aged 6-13 years: The TEDDY child study.
    Girardi P; Lupo A; Mastromatteo LY; Scrimin S
    Environ Res; 2023 Aug; 231(Pt 2):116049. PubMed ID: 37207732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal exposure to per- and polyfluoroalkyl substances and child behavioral problems.
    Choi JW; Oh J; Bennett DH; Calafat AM; Schmidt RJ; Shin HM
    Environ Res; 2024 Jun; 251(Pt 1):118511. PubMed ID: 38387490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
    Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
    Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In utero exposure to perfluoroalkyl and polyfluoroalkyl substances and attention and executive function in the offspring: A study in the Danish National Birth Cohort.
    Bach CC; Liew Z; Matthiesen NB; Henriksen TB; Bech BH; Nøhr EA; Bonefeld-Jørgensen EC; Olsen J
    Environ Res; 2022 Sep; 212(Pt B):113262. PubMed ID: 35405133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of diet with per- and polyfluoroalkyl substances in plasma and human milk in the New Hampshire Birth Cohort Study.
    Wang Y; Gui J; Howe CG; Emond JA; Criswell RL; Gallagher LG; Huset CA; Peterson LA; Botelho JC; Calafat AM; Christensen B; Karagas MR; Romano ME
    Sci Total Environ; 2024 Jul; 933():173157. PubMed ID: 38740209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal Exposure to Perfluoroalkyl Substances and Child Behavior at Age 12: A PELAGIE Mother-Child Cohort Study.
    Tillaut H; Monfort C; Rouget F; Pelé F; Lainé F; Gaudreau E; Cordier S; Warembourg C; Saint-Amour D; Chevrier C
    Environ Health Perspect; 2023 Nov; 131(11):117009. PubMed ID: 37971539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
    Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
    Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal and childhood traffic-related air pollution exposure and childhood executive function and behavior.
    Harris MH; Gold DR; Rifas-Shiman SL; Melly SJ; Zanobetti A; Coull BA; Schwartz JD; Gryparis A; Kloog I; Koutrakis P; Bellinger DC; Belfort MB; Webster TF; White RF; Sagiv SK; Oken E
    Neurotoxicol Teratol; 2016; 57():60-70. PubMed ID: 27350569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational and childhood exposure to per- and polyfluoroalkyl substances and cardiometabolic risk at age 12 years.
    Li N; Liu Y; Papandonatos GD; Calafat AM; Eaton CB; Kelsey KT; Cecil KM; Kalkwarf HJ; Yolton K; Lanphear BP; Chen A; Braun JM
    Environ Int; 2021 Feb; 147():106344. PubMed ID: 33418195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal and childhood perfluoroalkyl substances exposures and children's reading skills at ages 5 and 8years.
    Zhang H; Yolton K; Webster GM; Ye X; Calafat AM; Dietrich KN; Xu Y; Xie C; Braun JM; Lanphear BP; Chen A
    Environ Int; 2018 Feb; 111():224-231. PubMed ID: 29241079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal Plasma per- and Polyfluoroalkyl Substance Concentrations in Early Pregnancy and Maternal and Neonatal Thyroid Function in a Prospective Birth Cohort: Project Viva (USA).
    Preston EV; Webster TF; Oken E; Claus Henn B; McClean MD; Rifas-Shiman SL; Pearce EN; Braverman LE; Calafat AM; Ye X; Sagiv SK
    Environ Health Perspect; 2018 Feb; 126(2):027013. PubMed ID: 29488882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Concentrations of Per- and Polyfluoroalkyl Substances and Body Composition From Mid-Childhood to Early Adolescence.
    Janis JA; Rifas-Shiman SL; Seshasayee SM; Sagiv S; Calafat AM; Gold DR; Coull BA; Rosen CJ; Oken E; Fleisch AF
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3760-e3770. PubMed ID: 33740056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeled prenatal exposure to per- and polyfluoroalkyl substances in association with child autism spectrum disorder: A case-control study.
    Shin HM; Bennett DH; Calafat AM; Tancredi D; Hertz-Picciotto I
    Environ Res; 2020 Jul; 186():109514. PubMed ID: 32353786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.